AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

AIQ Limited

Regulatory Filings Mar 31, 2020

14788_rns_2020-03-31_505ff287-fcc0-4ea5-8e82-7566d1c36a62.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2563I

AIQ Limited

31 March 2020

31 March 2020

AIQ Limited

("AIQ" or the "Company")

Response to Share Price Movement

AIQ (LSE: AIQ), a special purpose acquisition company formed to undertake one or more acquisitions of a company or business in the e-commerce sector, notes the recent rise in the Company's share price and confirms that it is not aware of any material reason for the significant increase.

The Company published a prospectus on 20 March 2020 in which it outlined the acquisition (via a reverse takeover) of Alchemist Codes Sdn Bhd ("AIcodes") and its strategy for that business. Following a period of six months of suspension as part of the reverse takeover process, trading in AIQ's shares resumed with the completion of the acquisition on 26 March 2020. 

AIQ is now focused on implementing an operating strategy for Alcodes with a view to generating value for its shareholders through development and growth. However, it is too early to assess the impact that the global economic disruption as a result of the COVID-19 outbreak will have on the business and its ability to deliver in the short-term. The Company will update the market on progress with Alcodes as appropriate.

Enquiries

AIQ Limited

Graham Duncan, Chairman
+44 (0)754 900 5681
VSA Capital Limited - Financial Adviser and Broker

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)
+44 (0)20 3005 5000
Luther Pendragon (Media Relations)

Claire Norbury, Rachel So
+44 (0)20 7618 9100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

SPMFLFEFVFILVII

Talk to a Data Expert

Have a question? We'll get back to you promptly.